GIT1 and cancer: However, these studies generally report lower levels of heterogeneity (<20%) between primary and synchrononus lymph node metastases7,30, suggesting that GIT1 could be a more sensitive indicator of heterogeneity in this cancer, and hence a more powerful prognostic indicator.